Immunization studies for dengue serotype 2/4 vaccines using live-attenuated virus, adenoviral vector and envelope domain III fusion protein

碩士 === 國立清華大學 === 生物科技研究所 === 102 === 因申請專利緣故，資料延後公開

Bibliographic Details
Main Authors:	Tsai, Meng-Ju, 蔡孟如
Other Authors:	吳夙欽
Format:	Others
Language:	en_US
Published:	2014
Online Access:	http://ndltd.ncl.edu.tw/handle/9edqt9

id	ndltd-TW-102NTHU5111143
record_format	oai_dc
spelling	ndltd-TW-102NTHU51111432019-05-15T21:42:04Z http://ndltd.ncl.edu.tw/handle/9edqt9 Immunization studies for dengue serotype 2/4 vaccines using live-attenuated virus, adenoviral vector and envelope domain III fusion protein 以減毒活病毒、腺病毒載體及套膜蛋白第三區域融合蛋白作為第二、四型登革疫苗之免疫性研究 Tsai, Meng-Ju 蔡孟如碩士國立清華大學生物科技研究所 102 因申請專利緣故，資料延後公開吳夙欽 2014 學位論文 ; thesis 67 en_US
collection	NDLTD
language	en_US
format	Others
sources	NDLTD
description	碩士 === 國立清華大學 === 生物科技研究所 === 102 === 因申請專利緣故，資料延後公開
author2	吳夙欽
author_facet	吳夙欽 Tsai, Meng-Ju 蔡孟如
author	Tsai, Meng-Ju 蔡孟如
spellingShingle	Tsai, Meng-Ju 蔡孟如 Immunization studies for dengue serotype 2/4 vaccines using live-attenuated virus, adenoviral vector and envelope domain III fusion protein
author_sort	Tsai, Meng-Ju
title	Immunization studies for dengue serotype 2/4 vaccines using live-attenuated virus, adenoviral vector and envelope domain III fusion protein
title_short	Immunization studies for dengue serotype 2/4 vaccines using live-attenuated virus, adenoviral vector and envelope domain III fusion protein
title_full	Immunization studies for dengue serotype 2/4 vaccines using live-attenuated virus, adenoviral vector and envelope domain III fusion protein
title_fullStr	Immunization studies for dengue serotype 2/4 vaccines using live-attenuated virus, adenoviral vector and envelope domain III fusion protein
title_full_unstemmed	Immunization studies for dengue serotype 2/4 vaccines using live-attenuated virus, adenoviral vector and envelope domain III fusion protein
title_sort	immunization studies for dengue serotype 2/4 vaccines using live-attenuated virus, adenoviral vector and envelope domain iii fusion protein
publishDate	2014
url	http://ndltd.ncl.edu.tw/handle/9edqt9
work_keys_str_mv	AT tsaimengju immunizationstudiesfordengueserotype24vaccinesusingliveattenuatedvirusadenoviralvectorandenvelopedomainiiifusionprotein AT càimèngrú immunizationstudiesfordengueserotype24vaccinesusingliveattenuatedvirusadenoviralvectorandenvelopedomainiiifusionprotein AT tsaimengju yǐjiǎndúhuóbìngdúxiànbìngdúzàitǐjítàomódànbáidìsānqūyùrónghédànbáizuòwèidìèrsìxíngdēnggéyìmiáozhīmiǎnyìxìngyánjiū AT càimèngrú yǐjiǎndúhuóbìngdúxiànbìngdúzàitǐjítàomódànbáidìsānqūyùrónghédànbáizuòwèidìèrsìxíngdēnggéyìmiáozhīmiǎnyìxìngyánjiū
_version_	1719116875808374784

Immunization studies for dengue serotype 2/4 vaccines using live-attenuated virus, adenoviral vector and envelope domain III fusion protein

Similar Items